top of page

Earlier News

We help inventions grow!

2021-2022

Interview with Jaromír Zahrádka: Investments help science to serve people

The judges at Transfera Technology Day 2021 awarded the cream of the crop

i&i Prague supports the innovative PEP-Therapy in their extension of the Series-A ...

Enantis concluded a license agreement for the production of stabilised growth factor FGF2

PerioTrap Pharmaceuticals Raises €3M Seed Round to Develop Selective ...

Elphogene received a TA CR grant for “Sample prep system and technology for cancer ..."

Our notes from a trip to “The most startup friendly country in the whole world”

Spin-off CasInvent Pharma receives the Neuron Award for excellent Technology Transfer

Licensing agreement for a novel SARS Cov-2 virus neutralization antibody test was signed

i&i Prague supported LAM-X a.s. won the 2020 EIT Health MedTech Bootcamp final ...

UCT Prague entered in memorandum with i&i Prague, s.r.o.

i&i Prague announces its first exit, DIANA Biotechnologies is bought out by its founders

i&i Bio, the newly estabilished investment fund powered by i&i Prague and EIF

Green chemistry start-up Sulfotools closes seed round with i&i Prague

CasInvent Pharma, an University Spin-Off Focused on Developing Cancer Drugs...

Dracen Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With ...

2020-2018

Nanofibers from Technical University of Liberec brings new hope in fight against Covid-19

Enantis – first biotechnology spin-off from Masaryk University in Brno

DIANA Biotechnologies – technology that raised EUR 3M in 3 years

License for use of iBodies® bought by Immunotech, a member of the Beckman...

LAM-X: revolutionary wound-treating nanomaterials

Elphogene – liquid biopsy assay for non-invasive monitoring of patients with colorectal cancer

Novel partnership for iBodies has been facilitated by i&i Prague and IOCB Tech...

i&i Prague became a shareholder in the spin-off XENO Cell Innovations!

i&i Prague successfully mediated an out-licensing of antibodies from IMG

LAM-X – light-activated nanomaterials for face-masks and respirators

Elphogene: non-invasive screening of patients in advanced stages of cancer

DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies

iBodies – synthetic antibodies from Institute of Organic Chemistry and Biochemistry

Elphogene in World Journal of Gastroenterology!

A novel early cancer diagnostics method has been developed at University of Pardubice,...

Revolutionary type of catheter raised €2 million from private investors

i&i Prague co-invested Dracen Pharmaceuticals, a company developing a novel oncology...

Prague startup RIOCATH had recently entered market with its world-unique catheter!

Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects

LAM-X a.s. is collaborating with TUL to develop active nanofilters against COVID-19

iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity...

LAM-X: the spin-off accelerated by i&i Prague in Media

DIANA Biotechnologies, a novel startup in the i&i Prague´s academic incubator

Startup Riocath is among Hello Tomorrow’s top 500 stratups in the world

i&i Prague is joining Hello Tomorrow Ecosystem, a global community boosting deep...

bottom of page